Mucinex 12-Hour (Guaifenesin 600 mg) Dosing
For adults and children 12 years and older, take 1 or 2 extended-release tablets (600-1200 mg) every 12 hours, not exceeding 4 tablets in 24 hours; this medication is not approved for children under 12 years of age. 1
Administration Guidelines
Key dosing instructions from the FDA label include:
- Swallow tablets whole—do not crush, chew, or break the extended-release formulation 1
- Take with a full glass of water 1
- Can be taken without regard to meals 1
- Children under 12 years: do not use 1
Important Safety Considerations
Contraindications and warnings:
- Do not use in children under 12 years of age 1
- Consult a physician before use if you have persistent or chronic cough from smoking, asthma, chronic bronchitis, or emphysema 1
- Avoid if cough is accompanied by excessive phlegm 1
Stop use and seek medical attention if:
- Cough persists beyond 7 days 1
- Cough returns after improvement 1
- Fever, rash, or persistent headache develops—these may indicate serious illness 1
Clinical Context and Evidence Quality
The evidence supporting guaifenesin's efficacy is notably mixed. While it maintains FDA approval and OTC monograph status 2, recent high-quality research challenges its clinical benefit. A 2014 randomized controlled trial found that guaifenesin 1200 mg twice daily had no measurable effect on sputum volume, hydration, viscosity, or elasticity compared to placebo in patients with acute respiratory tract infections 3.
However, the medication demonstrates a favorable safety profile. A 2019 post-marketing surveillance study of 552 patients taking the same 1200 mg twice-daily regimen found only mild adverse events (primarily gastrointestinal and nervous system effects), with no serious adverse events or deaths 4.
Common pitfalls to avoid:
- Breaking or crushing the extended-release tablets, which destroys the 12-hour formulation 1
- Using in children under 12 years—this is explicitly contraindicated 1
- Continuing use beyond 7 days without medical evaluation 1
The extended-release formulation provides bioequivalent steady-state exposure to immediate-release guaifenesin dosed every 4 hours, offering dosing convenience 5.